Introduction: Crohn’s disease (CD) is a chronic inflammatory bowel condition characterized by transmural inflammation that can affect any part of the gastrointestinal tract (1) . Its management often requires long-term immunosuppressive therapy, including biologic agents such as tumor necrosis factor (TNF) antagonists (1). Since the approval of inf